These pathological changes were further supported by our biochemical analysis of WML tissue, which showed a significant decrease in PLP levels in AD, indicative of  axonal atrophy, as well as equal loss of MAG levels between AD and control brains, signifying demyelination in both groups. The gene discussed is MAG; the disease is Alzheimer disease.